N/A
N=52
Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes
Tobacco Use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT04996940 ↗Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Questionnaire Scale "Intentions for Future Use" — 3.1; 3.7 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- E-cigarette product (Device)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Kansas Medical Center
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Questionnaire Scale "Intentions for Future Use" |
3.1; 3.7 | — |
| SECONDARY Questionnaire Scale "Subjective Vaping Experience" |
38.0; 48.1 | — |
| SECONDARY Questionnaire Scale "Perceptions of Flavor" |
34.0; 51.0 | — |
| SECONDARY Questionnaire Scale "Product Demand" |
38.7; 49.7 | — |
Summary
The study is a randomized crossover trial. Current menthol smokers will complete a session with each flavor of an electronic cigarette: menthol and tobacco. The objective of this survey is to assess for flavor preference.
Eligibility Criteria
Inclusion Criteria
- typically smoking menthol cigarettes
- Non-Hispanic African American or white/Caucasian,
- ≥21 years old, smoke 5-30 cigarettes per day,
- daily cigarette smoker
- smoked at current rate for at least 6 months
- interested in trying e-cigarettes
- not interested in or unable/unwilling to quit cigarette smoking
- willing to complete one in-person study visits
Exclusion Criteria
- Interested in quitting cigarettes in the next 30 days
- use of smoking cessation pharmacotherapy in the past 30 days
- use of non-cigarette tobacco products in the past 30 days
- use of e-cigarettes >5x in lifetime
- use of e-cigarettes ≥4 of the past 30 days
- weight 10 miles from study site (Fairway CRU)
- current enrollment is a research study or program that aims to alter tobacco use
Data sourced from ClinicalTrials.gov (NCT04996940). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.